SPRYD4: A Potential Drug Target and Biomarker for Diseases (G283377)

Target Name: SPRYD4

NCBI ID: G283377

Other Name(s): SPRY4_HUMAN | SPRY domain-containing protein 4 | SPRY domain containing 4

SPRYD4: A Potential Drug Target and Biomarker for Diseases

SPRYD4 (SPRY4-HUMAN) is a protein that is expressed in human tissues and is known for its role in the development and progression of various diseases, including cancer. The SPRYD4 gene has also been identified as a potential drug target and biomarker for several diseases.

SPRYD4 is a member of the SPRY gene family, which is known for its role in the development and regulation of sensory neurons. The SPRYD4 gene is located on chromosome 12 and has been shown to encode a protein that is involved in several cellular processes, including cell signaling, DNA replication, and stress response.

SPRYD4 has been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of SPRYD4 are associated with poor prognosis in patients with pancreatic cancer, a highly aggressive form of cancer that is difficult to treat. Additionally, SPRYD4 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

SPRYD4 has also been identified as a potential drug target for several diseases. For example, SPRYD4 has been shown to be involved in the development of neuropsychiatric diseases, such as depression and anxiety. Additionally, SPRYD4 has been shown to be involved in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

In addition to its potential as a drug target, SPRYD4 has also been identified as a potential biomarker for several diseases. For example, studies have shown that SPRYD4 levels are elevated in the brains of patients with Alzheimer's disease, a neurodegenerative disease. Additionally, SPRYD4 has been shown to be involved in the development of cancer, which could make it an attractive biomarker for cancer detection and treatment.

Overall, SPRYD4 is a protein that has the potential to be a drug target and biomarker for several diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: SPRY Domain Containing 4

More Common Targets